Stocks crept lower on Friday as a selloff in health care extended into its second day, this time led by Amgen (AMGN) shares. Biogen (BIIB) tanked the sector a day earlier following an analyst downgrade. Amgen fell after its cholesterol drug showed weaker results than anticipated. Repatha reduced the risk of heart attacks and strokes by 15%, less than a target of at least 20%. Consumer sentiment ticked up at a faster pace in March than expected, according to a preliminary reading of the University of Michigan index. Barclays analysts note that strength supports GDP growth in the near term. Tiffany & Co. (TIF) rose after topping fourth-quarter estimates and providing upbeat guidance. Same-store sales over its holiday quarter came in flat, far better than an anticipated drop of more than 1%.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.